Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Mixtures of Acids03:27

Mixtures of Acids

22.1K
The pH of a solution containing an acid can be determined using its acid dissociation constant and its initial concentration. If a solution contains two different acids, then its pH can be determined using one of several methods depending upon the relative strength of the acids and their dissociation constants.
A Mixture of a Strong Acid and a Weak Acid
In a mixture of a strong acid and a weak acid, the strong acid dissociates completely and becomes a source of almost all the hydronium ions...
22.1K
Mixtures of Acids01:19

Mixtures of Acids

1.1K
The pH of a solution containing an acid can be determined using its acid dissociation constant and initial concentration. If a solution contains two different acids, then its pH can be determined using one of several methods depending on the relative strength of the acids and their dissociation constants.
In a strong and weak acid mixture, the strong acid dissociates completely and becomes a source of almost all the hydronium ions present in the solution. In contrast, the weak acid shows...
1.1K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

435
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
435

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimation of exponential rates in non-homogeneous populations using the EAIR estimator.

Journal of biopharmaceutical statistics·2026
Same author

The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis.

Kidney international·2025
Same author

Estimand Framework and Statistical Considerations for Integrated Analysis of Clinical Trial Safety Data.

Therapeutic innovation & regulatory science·2024
Same author

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data.

Statistics in medicine·2024
Same author

Overview of modern approaches for identifying and evaluating heterogeneous treatment effects from clinical data.

Clinical trials (London, England)·2023
Same author

Analysis and reporting of pediatric growth and development assessment from clinical trials: overview and challenges.

Journal of biopharmaceutical statistics·2022
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Feb 16, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Mixture-based gatekeeping procedures in adaptive clinical trials.

George Kordzakhia1, Alex Dmitrienko2, Eiji Ishida1

  • 1a U.S. Food and Drug Administration , Silver Spring , Maryland , USA.

Journal of Biopharmaceutical Statistics
|December 29, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a new framework for adaptive clinical trials to manage multiple objectives and statistical testing complexities. It uses a mixture method and combination function approach for powerful, data-driven decision-making in multistage designs.

Keywords:
Adaptive designsclinical trialsclosed testingcombination functionsgatekeeping proceduresmultiple testing

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K

Related Experiment Videos

Last Updated: Feb 16, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

7.3K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methodology

Background:

  • Clinical trials frequently involve complex objectives, leading to multivariate multiplicity issues.
  • Existing methods may lack flexibility in handling diverse hypotheses and data-driven decisions.

Purpose of the Study:

  • To propose a general framework for gatekeeping procedures in adaptive multistage clinical trials.
  • To enable powerful and flexible statistical testing strategies for complex trial objectives.

Main Methods:

  • Application of the mixture method to construct stage-specific gatekeeping procedures.
  • Utilization of the combination function approach for inference at interim and final analyses.
  • Development of an adaptive two-stage design example.

Main Results:

  • The proposed framework provides a powerful gatekeeping procedure adaptable to complex logical relationships among hypotheses.
  • The combination function approach facilitates flexible data-driven decisions, including sample size adjustments or treatment arm removal.
  • A clinical trial example demonstrates the practical application of the methodology.

Conclusions:

  • The developed framework offers a robust solution for managing multiplicity in adaptive clinical trials.
  • This approach enhances the efficiency and flexibility of complex clinical trial designs.
  • It supports data-driven decision-making throughout the trial lifecycle.